GL is a heterogeneous congenital disease (CGL) or acquired disease (AGL) characterized by loss of adipose tissue and increased insulin resistance, and an increased predisposition to metabolic complications, such as DM, hypertriglyceridemia, and hepatic steatosis (54). The gene discussed is INS; the disease is diabetes mellitus.